80 related articles for article (PubMed ID: 19622620)
21. Monitoring treatment in pediatric patients with 21-hydroxylase deficiency.
Itonaga T; Hasegawa Y
Front Endocrinol (Lausanne); 2023; 14():1102741. PubMed ID: 36843618
[TBL] [Abstract][Full Text] [Related]
22. Clinical guidelines for the diagnosis and treatment of 21-hydroxylase deficiency (2021 revision).
Ishii T; Kashimada K; Amano N; Takasawa K; Nakamura-Utsunomiya A; Yatsuga S; Mukai T; Ida S; Isobe M; Fukushi M; Satoh H; Yoshino K; Otsuki M; Katabami T; Tajima T
Clin Pediatr Endocrinol; 2022; 31(3):116-143. PubMed ID: 35928387
[TBL] [Abstract][Full Text] [Related]
23. Adrenal crises in adolescents and young adults.
Rushworth RL; Chrisp GL; Bownes S; Torpy DJ; Falhammar H
Endocrine; 2022 Jun; 77(1):1-10. PubMed ID: 35583847
[TBL] [Abstract][Full Text] [Related]
24. The utility of annual growth velocity standard deviation scores and measurements of biochemical parameters in long-term treatment monitoring of children with 21-hydroxylase deficiency.
Ozdemir Dilek S; Turan I; Gurbuz F; Celiloglu C; Yuksel B
Hormones (Athens); 2022 Sep; 21(3):391-397. PubMed ID: 35243601
[TBL] [Abstract][Full Text] [Related]
25. Characteristics of Growth in Children With Classic Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency During Adrenarche and Beyond.
Troger T; Sommer G; Lang-Muritano M; Konrad D; Kuhlmann B; Zumsteg U; Flück CE
J Clin Endocrinol Metab; 2022 Jan; 107(2):e487-e499. PubMed ID: 34599587
[TBL] [Abstract][Full Text] [Related]
26. Hydrocortisone dosing in children with classic congenital adrenal hyperplasia: results of the German/Austrian registry.
Hoyer-Kuhn H; Huebner A; Richter-Unruh A; Bettendorf M; Rohrer T; Kapelari K; Riedl S; Mohnike K; Dörr HG; Roehl FW; Fink K; Holl RW; Woelfle J
Endocr Connect; 2021 May; 10(5):561-569. PubMed ID: 33909597
[TBL] [Abstract][Full Text] [Related]
27. Does fludrocortisone treatment cause hypomagnesemia in children with primary adrenal insufficiency?
Erbaş İM; Altincik SA; Çatli G; Ünüvar T; Özhan B; Abaci A; Anik A
Turk J Med Sci; 2021 Feb; 51(1):231-237. PubMed ID: 33155789
[TBL] [Abstract][Full Text] [Related]
28. Histrelin Implantation and Growth Outcomes in Children With Congenital Adrenal Hyperplasia: An Institutional Experience.
Swendiman RA; Coons BE; Alter CA; Bamba V; Nance ML; Vogiatzi MG
J Endocr Soc; 2020 Feb; 4(2):bvz004. PubMed ID: 32104750
[TBL] [Abstract][Full Text] [Related]
29. Metabolic Perspectives for Non-classical Congenital Adrenal Hyperplasia With Relation to the Classical Form of the Disease.
Macut D; Zdravković V; Bjekić-Macut J; Mastorakos G; Pignatelli D
Front Endocrinol (Lausanne); 2019; 10():681. PubMed ID: 31632355
[TBL] [Abstract][Full Text] [Related]
30. Congenital Adrenal Hyperplasia and Growth Outcomes.
Sharma R
Indian J Pediatr; 2019 Feb; 86(2):111-112. PubMed ID: 30607772
[No Abstract] [Full Text] [Related]
31. Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline.
Speiser PW; Arlt W; Auchus RJ; Baskin LS; Conway GS; Merke DP; Meyer-Bahlburg HFL; Miller WL; Murad MH; Oberfield SE; White PC
J Clin Endocrinol Metab; 2018 Nov; 103(11):4043-4088. PubMed ID: 30272171
[TBL] [Abstract][Full Text] [Related]
32. Long-term Growth in Congenital Adrenal Hyperplasia.
Maheshwari A; Khadilkar V; Gangodkar P; Khadilkar A
Indian J Pediatr; 2019 Feb; 86(2):154-158. PubMed ID: 30097840
[TBL] [Abstract][Full Text] [Related]
33. Severe Short Stature in an Adolescent Male with Prader-Willi Syndrome and Congenital Adrenal Hyperplasia: A Therapeutic Conundrum.
Wasserman M; Mulvihill EM; Ganan-Soto A; Uysal S; Quintos JB
Case Rep Endocrinol; 2017; 2017():4271978. PubMed ID: 28638668
[TBL] [Abstract][Full Text] [Related]
34. Novel treatment strategies in congenital adrenal hyperplasia.
Turcu AF; Auchus RJ
Curr Opin Endocrinol Diabetes Obes; 2016 Jun; 23(3):225-32. PubMed ID: 27032061
[TBL] [Abstract][Full Text] [Related]
35. Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline.
Bornstein SR; Allolio B; Arlt W; Barthel A; Don-Wauchope A; Hammer GD; Husebye ES; Merke DP; Murad MH; Stratakis CA; Torpy DJ
J Clin Endocrinol Metab; 2016 Feb; 101(2):364-89. PubMed ID: 26760044
[TBL] [Abstract][Full Text] [Related]
36. Guidelines for diagnosis and treatment of 21-hydroxylase deficiency (2014 revision).
; ; ; Ishii T; Anzo M; Adachi M; Onigata K; Kusuda S; Nagasaki K; Harada S; Horikawa R; Minagawa M; Minamitani K; Mizuno H; Yamakami Y; Fukushi M; Tajima T
Clin Pediatr Endocrinol; 2015 Jul; 24(3):77-105. PubMed ID: 26594092
[TBL] [Abstract][Full Text] [Related]
37. Adrenal steroidogenesis and congenital adrenal hyperplasia.
Turcu AF; Auchus RJ
Endocrinol Metab Clin North Am; 2015 Jun; 44(2):275-96. PubMed ID: 26038201
[TBL] [Abstract][Full Text] [Related]
38. Transplantation of bovine adrenocortical cells encapsulated in alginate.
Balyura M; Gelfgat E; Ehrhart-Bornstein M; Ludwig B; Gendler Z; Barkai U; Zimerman B; Rotem A; Block NL; Schally AV; Bornstein SR
Proc Natl Acad Sci U S A; 2015 Feb; 112(8):2527-32. PubMed ID: 25675525
[TBL] [Abstract][Full Text] [Related]
39. Abiraterone acetate to lower androgens in women with classic 21-hydroxylase deficiency.
Auchus RJ; Buschur EO; Chang AY; Hammer GD; Ramm C; Madrigal D; Wang G; Gonzalez M; Xu XS; Smit JW; Jiao J; Yu MK
J Clin Endocrinol Metab; 2014 Aug; 99(8):2763-70. PubMed ID: 24780050
[TBL] [Abstract][Full Text] [Related]
40. Management of adolescents with congenital adrenal hyperplasia.
Merke DP; Poppas DP
Lancet Diabetes Endocrinol; 2013 Dec; 1(4):341-52. PubMed ID: 24622419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
